Hysteroscopic Bubble Suction Test and Tubal Peristalsis (Darwish Test) in Hydrosalpnix
NCT ID: NCT03953586
Last Updated: 2020-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2019-12-10
2020-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In 2016, hysteroscopy as a predictor test of tubal patency and tubal peristalsis was introduced. It is concluded that hysteroscopic bubble suction test is a good initial screening test for tubal patency nearly comparable to HSG and DL. It should be attempted in every case of OH prior to referral for more invasive HSG or laparoscopic chromopertubation test.
Thereafter, some authors tried the same idea of bubble suction test and were over-enthusiastic with this test and considered it superior to hysterosalpingography (HSG) in detection of tubal patency in infertile women. They wrongly described HSG as a historic tool despite being recommended as a basic infertility test by many organizations. Some authors criticized the results of these studies and underestimated their clinical implication. One of the objections were lack of differentiation between normal tubes and damaged or narrowed but still patent tubes.
Aim of the work:
To test whether bubble suction test and osteal peristalsis are preserved or lost in cases with hydrosalpnix.
Design: A prospective double blinded randomized controlled trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bubble suction test and peristalsis in hydrosalpnix
. Group A: Women with unilateral or bilateral blockage of the distal end of the fallopian tubes with tubal distension.
Bubble suction test and tubal peristalsis
Efficacy of this test in cases of hydrosalpnix (group A) and normal tubes (group B)
bubble suction test and peristalsis in normal tubes
Group B: Women with normal appearance of the fallopian tubes by HSG.
Bubble suction test and tubal peristalsis
Efficacy of this test in cases of hydrosalpnix (group A) and normal tubes (group B)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bubble suction test and tubal peristalsis
Efficacy of this test in cases of hydrosalpnix (group A) and normal tubes (group B)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Woman's Health University Hospital, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Atef Darwish
Professor of Obstetrics and Gynecology, Assiut University, Assiut, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Woman's Health University Hospital
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WomansHealthUHEgypt
Identifier Type: -
Identifier Source: org_study_id